Healthcare
Live Price
Offline$14.79
+0.48% today
1Y Change
-17.60%
Window
Jun 25, 2025 → Jun 18, 2026
Coverage: 248 bars · Jun 25, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
NovoCure Limited (NVCR) is a Healthcare stock with a market cap of $1.89B and listed on NASDAQ. The stock last traded around $14.79 and down 17.6% across the available one-year price window (Jun 25, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +8.3%, EPS growth of +21.8%, a dividend yield of 0.0%. What stands out right now is revenue +8.3%, EPS +21.8%, free cash flow -9.3% with operating margin -27.2% and ROIC -31.8%. Valuation is more restrained than many high-expectation growth names at price/sales 2.8. Stock Foundry combines NVCR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NVCR
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NVCR Max Drawdown
-45.67%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for NVCR and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+8.3%
EPS Growth
+21.8%
Gross Margin
75.2%
Net Margin
-25.7%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.